APPLIED INDUSTRIAL TECHNOLOGIES INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data APPLIED INDUSTRIAL TECHNOLOGIES INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	2,594	3,073	3,473	3,246	3,236	3,811	4,413	4,479	4,563	4,967
Cost of revenue	1,856	2,189	2,465	2,308	2,300	2,704	3,126	3,143	3,180	3,460
Gross profit	738	884	1,008	938	936	1,107	1,287	1,337	1,383	1,507
Selling, general and administrative	562	658	742	718	681	749	814	841	885	957
Operating income	175	226	234	89	205	358	473	496	499	549
Interest expense	8.83	24.1	40.8	37.3	30.8	26.8	24.8	20.5	18.2	17.4
Interest income	0.29	0.66	0.6	0.73	0.22	0.52	3.15	17.7	17.6	9.45
Other non-operating income	0.12	2.38	0.88	2.78	2.2	-1.81	-1.7	5.14	3.05	2.74
Pre-tax income	167	205	194	55.2	177	330	450	498	501	544
Income tax	33.1	63.1	50.5	31.2	32.3	72.4	103	112	108	130
Net income	134	142	144	24	145	257	347	386	393	415
EBITDA	191	244	254	110	226	380	495	519	523	575
EPS, basic	3.43	3.65	3.72	0.62	3.73	6.69	8.98	9.98	10.26	11.09
EPS, diluted	3.40	3.61	3.68	0.62	3.68	6.58	8.84	9.83	10.12	10.95
Shares, basic (weighted)	39	38.8	38.7	38.7	38.8	38.5	38.6	38.7	38.3	37.4
Shares, diluted (weighted)	39.4	39.3	39.2	39	39.3	39.1	39.2	39.3	38.8	37.9
Dividend per share	1.14	1.18	1.22	1.26	1.30	1.34	1.38	1.44	1.66	1.99

Balance sheet

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	105	54.2	108	269	258	184	344	461	388	127
Receivables	391	549	541	450	516	656	708	725	770	831
Inventory	345	422	448	389	363	450	501	488	505	509
Other current assets	41.4	33	51.5	52.1	60	68.8	93.2	96.1	84	111
Total current assets	883	1,058	1,148	1,160	1,197	1,360	1,647	1,770	1,747	1,579
Property, plant and equipment	108	121	124	122	116	112	115	119	128	132
Lease right-of-use assets			0	90.6	87.1	108	101	133	189	213
Goodwill	206	647	662	541	560	563	578	619	699	705
Intangible assets	164	436	369	343	280	251	236	246	349	313
Other non-current assets	27.3	23.8	28.4	27.4	32.8	59.3	66.8	64.9	63.3	68.9
Total assets	1,388	2,286	2,332	2,284	2,272	2,453	2,743	2,952	3,176	3,010
Accounts payable	181	257	237	186	208	259	302	267	280	341
Accrued liabilities	58.8	73.4	68	61.9	77.7	91.2	98.7	93.2	99.6	109
Short-term debt	4.81	19.2	49	78.6	43.5	40.2	25.2	25.1	0
Total current liabilities	310	433	424	426	428	500	540	501	526	612
Long-term debt	287	945	909	855	785	649	597	572	572	262
Lease liabilities									159	168
Other non-current liabilities	29.1	93.7	102	159	127	154	148	190	233	274
Total liabilities	642	1,471	1,435	1,440	1,339	1,303	1,285	1,263	1,331	1,148
Total debt	292	964	958	934	828	689	622	597	572	262
Paid-in capital	165	169	173	176	177	184	189	194	199	205
Retained earnings	1,034	1,130	1,229	1,201	1,294	1,500	1,793	2,122	2,448	2,789
Treasury stock	-381	-404	-415	-414	-456	-472	-478	-559	-721	-1,047
Other comprehensive income	-81.7	-90.2	-99.9	-129	-93.1	-72.3	-55.3	-77.6	-91.7	-94.8
Shareholders' equity	745	815	897	844	933	1,149	1,458	1,689	1,845	1,862
Total equity	745	815	897	844	933	1,149	1,458	1,689	1,845	1,862
Total liabilities and equity	1,388	2,286	2,332	2,284	2,272	2,453	2,743	2,952	3,176	3,010
Shares outstanding	39	38.7	38.6	38.7	38.5	38.5	38.7	38.4	37.9	36.8

Cash flow statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	134	142	144	24	145	257	347	386	393	415
Depreciation and amortization	15.3	17.8	20.2	21.2	20.8	21.7	22.3	23.4	24.9	25.9
Stock-based compensation	3.63	4.67	4.47	4	8.98	11.8	12.4	12.9	12	12.9
Deferred income tax	-2.85	1.62	2.37	-13.3	-31.1	15.2	-5.72	-1.07	-6.36	26.3
Change in receivables	-42.3	-83.1	8.47	74.4	-59.1	-146	-51.1	-1.93	-4.92	-66.4
Change in inventory	-3.62	-33.4	-16.6	57	41.3	-92.4	-43	18.4	29.2	-0.9
Change in payables	32.1	50.3	-29.8	-53.9	10.9	53.6	37.7	-39.3	2.17	56.9
Cash from operations	165	147	181	297	242	188	344	371	492	484
Capital expenditures	-17	-23.2	-19	-20.1	-15.9	-18.1	-26.5	-24.9	-27.2	-23.6
Acquisitions	-2.77	-776	-37.5	-37.2	-30.2	-6.96	-35.8	-72.1	-293	-11.4
Cash from investing	-16.9	-798	-55.1	-55.4	-44.9	-35.7	-60.8	-95.4	-319	-33.9
Stock issued	0.66	0.1	0	0.33	0.16	0.56	0.13	0.13	0	0
Share buybacks	-8.24	-22.8	-11.2	0	-40.1	-13.8	-0.72	-73.4	-153	-317
Dividends paid	-44.6	-45.9	-47.3	-48.9	-50.7	-51.8	-53.4	-55.9	-63.7	-72.6
Cash from financing	-103	600	-71.5	-78.2	-213	-223	-127	-156	-246	-712
Exchange rate effect	0.82	-0.59	0.11	-2.74	5.46	-2.15	3.32	-2.94	-0.23	0.07
Net change in cash	45.2	-50.9	54.1	160	-10.8	-73.3	160	117	-72.2	-261
Free cash flow	148	124	162	277	226	169	317	347	465	461
Interest paid	8.56	25.6	40.1	36.6	27.5	20.2	22.6	24	21.8	19
Income taxes paid	38.8	41.7	54.3	41.2	64.4	53.3	108	116	108	109

Key metrics

Worked out from the statements above. Latest values use fiscal 2026. Valuation uses the share price of $333.39 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	30.3%	Gross profit / revenue.
Operating margin	11.1%	Operating income / revenue.
EBITDA margin	11.6%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	11.0%	Pre-tax income / revenue.
Net margin	8.3%	Net income / revenue.
FCF margin	9.3%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	9.7%	Cash from operations / revenue.
Effective tax rate	23.8%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	22.4%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	13.4%	Net income / average total assets.
Return on invested capital (ROIC)	20.8%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	19.3%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.3%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	0.5%	Capital expenditures / revenue.
D&A / revenue	0.5%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	8.8%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	4.0%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	8.9%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	8.9%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	5.4%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	10.0%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	10.2%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	5.1%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	21.7%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	9.9%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	5.1%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	20.5%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	5.5%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	6.1%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	23.4%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	8.2%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	7.4%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	24.4%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-1.7%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	12.1%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	14.9%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-1.0%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	13.2%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	15.3%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	19.9%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	13.0%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	8.9%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	0.9%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	8.5%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	14.8%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-5.2%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	3.1%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	5.8%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-2.5%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-1.2%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-0.7%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.58x	Current assets / current liabilities.
Quick ratio	1.56x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.21x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.14x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	8.7%	Total debt / total assets.
Liabilities / assets	38.1%	Total liabilities / total assets.
Net debt	$135.2M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	0.23x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	31.6x	Operating income / interest expense.
Working capital	$966.3M	Current assets - current liabilities.
Goodwill and intangibles / assets	33.8%	(Goodwill + intangible assets) / total assets.
Tangible book value	$844.2M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.61x	Revenue / average total assets.
Fixed asset turnover	38.2x	Revenue / average property, plant and equipment.
Inventory turnover	6.82x	Cost of revenue / average inventory.
Days inventory	54 days	365 x average inventory / cost of revenue.
Receivables turnover	6.20x	Revenue / average receivables.
Days sales outstanding	59 days	365 x average receivables / revenue.
Days payables	33 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	80 days	Days inventory + days sales outstanding - days payables.
FCF conversion	111.1%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	4.9%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$10.95	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic	$11.09	Net income per basic share, as reported (split-adjusted).
Revenue per share	$131.20	Revenue / diluted weighted shares.
FCF per share	$12.16	Free cash flow / diluted weighted shares.
Operating cash flow per share	$12.79	Cash from operations / diluted weighted shares.
Book value per share	$50.59	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$22.94	Tangible book value / shares outstanding.
Cash per share	$3.45	(Cash + short-term investments) / shares outstanding.
Dividend per share	$1.99	Dividend declared per common share (paid, when declared is not tagged).
Payout ratio	17.5%	Dividends paid / net income, when net income is positive.
Dividends / FCF	15.8%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	68.9%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$12.24B	Share price x shares outstanding.
Enterprise value	$12.37B	Market cap + total debt - cash - short-term investments.
P/E	29.5x	Market cap / net income. Only when net income is positive.
P/S	2.46x	Market cap / revenue.
P/B	6.57x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	14.5x	Market cap / tangible book value, when positive.
P/FCF	26.6x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	25.3x	Market cap / cash from operations, when positive.
EV/Sales	2.49x	Enterprise value / revenue.
EV/EBIT	22.5x	Enterprise value / operating income, when both are positive.
EV/EBITDA	21.5x	Enterprise value / EBITDA, when both are positive.
EV/FCF	26.9x	Enterprise value / free cash flow, when both are positive.
FCF yield	3.8%	Free cash flow / market cap.
Earnings yield	3.4%	Net income / market cap (the inverse of P/E).
Dividend yield	0.6%	Dividends paid over the period / market cap.
Shareholder yield	3.2%	(Dividends paid + share buybacks) / market cap.
PEG	3.99x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was APPLIED INDUSTRIAL TECHNOLOGIES INC's revenue in fiscal 2026?

APPLIED INDUSTRIAL TECHNOLOGIES INC reported revenue of $4.97B for fiscal 2026, 8.8% higher than the year before.

Was APPLIED INDUSTRIAL TECHNOLOGIES INC profitable in fiscal 2026?

Yes. Net income was $414.5M, a net margin of 8.3%.

How much free cash flow did APPLIED INDUSTRIAL TECHNOLOGIES INC generate in fiscal 2026?

Cash from operations of $484.1M minus capital expenditures of $23.6M left free cash flow of $460.5M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to APPLIED INDUSTRIAL TECHNOLOGIES INC